Page last updated: 2024-10-28

haloperidol and Dementia

haloperidol has been researched along with Dementia in 102 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research Excerpts

ExcerptRelevanceReference
"When comparing treatment effects on individual symptoms frequently occurring in patients with dementia, risperidone significantly improved symptoms of agitation, wandering, diurnal rhythm disturbance and anxieties, among other symptoms, compared with haloperidol."9.12Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia. ( Choi, SK; Greenspan, AJ; Suh, GH, 2006)
"The authors compared the efficacy and side effects of trazodone and haloperidol for treating agitated behaviors associated with dementia."9.08A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. ( Berisford, MA; Gray, KF; Gunay, I; Mahler, ME; Sultzer, DL, 1997)
"The efficacy and safety of risperidone, haloperidol, and thioridazine for treating dementia-associated behavioral disturbances were evaluated in a retrospective study of 186 patients aged 65 years or older with DSM-III-R or DSM-IV diagnoses of Alzheimer's dementia, senile dementia NOS, or organic brain syndrome."9.08Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances. ( Frenchman, IB; Prince, T, 1997)
"The therapeutic effects in senile dementia of haloperidol and cis(Z)-clopenthixol were compared in a double-blind, double-dummy clinical 8-week study in 47 demented patients after wash-out periods of 3 weeks or less."9.05A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia. ( Götestam, KG; Ljunghall, S; Olsson, B, 1981)
"The CDCIG Specialized Register was searched to identify all available reports on haloperidol treatment of agitated dementia."8.81Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2001)
" Haloperidol has been used for decades to control agitation in dementia, but its effectiveness remains unclear."8.81Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2002)
"The aim of this study was to compare the efficacy and side-effect profile of the typical antipsychotic haloperidol with that of the atypical antipsychotics risperidone, olanzapine, and aripiprazole in the management of delirium."7.81Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects. ( Boettger, S; Breitbart, W; Jenewein, J, 2015)
"Treatment with haloperidol has been shown, in studies using death certificates and prescription files, to be associated with an excess of sudden cardiac deaths, and regulatory warnings highlight this risk in patients with dementia."7.81Haloperidol and sudden cardiac death in dementia: autopsy findings in psychiatric inpatients. ( Correll, CU; Grudnikoff, E; Ifteni, P; Kane, JM; Koppel, J; Kremen, N; Manu, P, 2015)
" Using an optimizing dosage regime, the outcome variables studied were aggression frequency and the number and nature of emergent side effects."6.67Aggression in the demented patient: a double-blind study of loxapine versus haloperidol. ( Ancill, RJ; Carlyle, W; Sheldon, L, 1993)
"When comparing treatment effects on individual symptoms frequently occurring in patients with dementia, risperidone significantly improved symptoms of agitation, wandering, diurnal rhythm disturbance and anxieties, among other symptoms, compared with haloperidol."5.12Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia. ( Choi, SK; Greenspan, AJ; Suh, GH, 2006)
" In 3 double-blind studies, acutely agitated patients with schizophrenia (N = 311), bipolar mania (N = 201), or dementia (N = 206) were treated with intramuscular (1-3 injections/24 hrs) olanzapine (2."5.10Calming versus sedative effects of intramuscular olanzapine in agitated patients. ( Alaka, K; Battaglia, J; Lindborg, SR; Meehan, K; Wright, P, 2003)
" Databases included: placebo-controlled [two schizophrenia, one bipolar mania trials (n=565)]; haloperidol-controlled [two schizophrenia trials (n=482)]; geriatric placebo-controlled [1 dementia trial (n=204)]."5.10Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients. ( Alaka, K; Beasley, CM; Lindborg, SR; Taylor, CC, 2003)
"The authors compared the efficacy and side effects of trazodone and haloperidol for treating agitated behaviors associated with dementia."5.08A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. ( Berisford, MA; Gray, KF; Gunay, I; Mahler, ME; Sultzer, DL, 1997)
"The efficacy and safety of risperidone, haloperidol, and thioridazine for treating dementia-associated behavioral disturbances were evaluated in a retrospective study of 186 patients aged 65 years or older with DSM-III-R or DSM-IV diagnoses of Alzheimer's dementia, senile dementia NOS, or organic brain syndrome."5.08Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances. ( Frenchman, IB; Prince, T, 1997)
"Fifty-nine elderly residents of long-term care facilities who had DSM-III diagnoses of dementia were studied in an 8-week randomized, double-blind comparison trial of haloperidol, oxazepam, and diphenhydramine to test the efficacy of these agents in the treatment of clinically significant behavioral disturbances in patients with dementia."5.06Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. ( Coccaro, EF; Duvvi, K; Giordani, B; Kramer, E; Nora, R; Patel, BM; Rice, CM; Thorne, A; Torres, J; Zemishlany, Z, 1990)
"The therapeutic effects in senile dementia of haloperidol and cis(Z)-clopenthixol were compared in a double-blind, double-dummy clinical 8-week study in 47 demented patients after wash-out periods of 3 weeks or less."5.05A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia. ( Götestam, KG; Ljunghall, S; Olsson, B, 1981)
"There is a discrepancy in the decisions on the marketing authorization vs the reimbursement in Lithuania and Latvia (reimbursement of haloperidol and trihexyphenidyl for the off-label treatment of dementia)."5.01Off-Label Use of Antipsychotic Agents in Dementia: Evidence for the Revision of the Reimbursement Policy. ( Jankūnas, RJ; Lesauskaitė, V; Stakišaitis, D; Zamarytė-Sakavičienė, K, 2019)
"The CDCIG Specialized Register was searched to identify all available reports on haloperidol treatment of agitated dementia."4.81Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2001)
" Haloperidol has been used for decades to control agitation in dementia, but its effectiveness remains unclear."4.81Haloperidol for agitation in dementia. ( Colford, J; Lonergan, E; Luxenberg, J, 2002)
"The findings of this cohort study suggest that the discontinuation rate of newly initiated APMs for delirium following infection-related hospitalization was lower in atypical APM users than in haloperidol users, with prolonged hospitalization and dementia as major associated variables."4.31Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization. ( Bessette, LG; Lin, KJ; Wilkins, JM; Wong, V; York, C; Zhang, Y, 2023)
"The aim of this study was to compare the efficacy and side-effect profile of the typical antipsychotic haloperidol with that of the atypical antipsychotics risperidone, olanzapine, and aripiprazole in the management of delirium."3.81Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects. ( Boettger, S; Breitbart, W; Jenewein, J, 2015)
"Treatment with haloperidol has been shown, in studies using death certificates and prescription files, to be associated with an excess of sudden cardiac deaths, and regulatory warnings highlight this risk in patients with dementia."3.81Haloperidol and sudden cardiac death in dementia: autopsy findings in psychiatric inpatients. ( Correll, CU; Grudnikoff, E; Ifteni, P; Kane, JM; Koppel, J; Kremen, N; Manu, P, 2015)
" Department of Veterans Affairs (fiscal years 1999-2008) for dementia patients age 65 and older who began outpatient treatment with an antipsychotic (risperidone, olanzapine, quetiapine, or haloperidol) or valproic acid and its derivatives (as a nonantipsychotic comparison)."3.78Risk of mortality among individual antipsychotics in patients with dementia. ( Blow, FC; Chiang, C; Cunningham, F; Kales, HC; Kim, HM; Schneider, LS; Seyfried, LS; Valenstein, M; Zivin, K, 2012)
"Age, use of opioids, and haloperidol were associated with persistent delirium."3.76Factors associated with persistent delirium after intensive care unit admission in an older medical patient population. ( Araujo, KL; Murphy, TE; Pisani, MA; Van Ness, PH, 2010)
"Medical records were reviewed retrospectively to identify consecutive patients who were admitted to our neuropsychiatry service with the presenting complaint of dementia (DSM-IV) with agitation and who were given intramuscular ziprasidone and then administered an electrocardiogram (ECG) (N = 23)."3.73A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients. ( Brown, FW; Greco, KE; Tune, LE; Van Horn, WA, 2005)
"Neuroleptic malignant syndrome occurred in a 71-year-old man on haloperidol therapy for mild depressive dementia."3.71Neuroleptic malignant syndrome: uncommon postoperative diagnostic dilemma. ( Bhan, S; Kulkarni, V; Mehta, Y; Sharma, KK; Suri, ML; Trehan, N, 2002)
" This diabetes insipidus is reversible, non-progressive, unrelated to plasma level, and distinct in attack from lithium-induced hypothyroidism, which may occur at low dosage but is also usually of late onset and reversible or treatable with thyroxine while lithium is continued."3.65Blood levels and management of lithium treatment. ( Crammer, JL; Crane, G; Rosser, RM, 1974)
" Dosing strategies, discontinuation considerations, and side effects are discussed."2.72The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia. ( Chen, A; Cloutier, A; Copeli, F; Metzger, E; Osser, DN, 2021)
"Haloperidol was prescribed for 68 percent of the patients."2.68Neuroleptic treatment of elderly patients. ( Alvir, JM; Kane, JM; Lieberman, JA; Saltz, BL; Woerner, MG, 1995)
" Using an optimizing dosage regime, the outcome variables studied were aggression frequency and the number and nature of emergent side effects."2.67Aggression in the demented patient: a double-blind study of loxapine versus haloperidol. ( Ancill, RJ; Carlyle, W; Sheldon, L, 1993)
"Haloperidol decanoate was thus shown to be therapeutically effective and it can be administered safely to geriatric patients."2.65Tolerance and serum levels of haloperidol during parenteral and oral haloperidol treatment in geriatric patients. ( Gordin, A; Lamminsivu, U; Salo, H; Viukari, M, 1982)
"The occurrence of confusion in the elderly patient should alert the physician to the need of investigation to detect underlying severe disease without delay."2.39[Confusional states in the elderly--an underdiagnosed syndrome with a poor prognosis]. ( Pitkälä, K, 1996)
"Recently, some cases of neuroleptic malignant syndrome (NMS) in demented patients have been reported, because the demented patients, who were administered neuroleptics due to their abnormal behaviors, have increased."2.39[Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases]. ( Kimura, T; Yoshida, H, 1994)
" As a group, the atypical antipsychotics (olanzapine, quetiapine, and risperidone) showed a dose-response increase in mortality risk, with 3."1.42Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. ( Chiang, C; Kales, HC; Kavanagh, J; Kim, HM; Maust, DT; Schneider, LS; Seyfried, LS, 2015)
"Haloperidol was associated with higher mortality risk (HR 30 days = 1."1.40Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study. ( Aarsland, D; Ballard, C; Engdahl, B; Langballe, EM; Nordeng, H; Selbæk, G, 2014)
" There was a dose-response relation for all drugs except quetiapine."1.38Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. ( Avorn, J; Crystal, S; Gerhard, T; Huybrechts, KF; Levin, R; Lucas, JA; Olfson, M; Schneeweiss, S, 2012)
" Further investigations are warranted to identify patient characteristics and antipsychotic dosage regimens that are not associated with a greater risk of mortality in elderly patients with dementia."1.36Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia? ( Dysken, MW; Lederle, FA; Rector, TS; Rossom, RC, 2010)
"Constipation was very troublesome and he often needed enema to prevent intestinal obstruction."1.34Minimizing antipsychotic medication obviated the need for enema against severe constipation leading to paralytic ileus: a case report. ( Kashima, H; Suzuki, T; Uchida, H; Watanabe, K, 2007)
"The pattern of myoclonus is unlike previous reported cases and may relate to activation of serotonin 5HT1A receptors (possibly supersensitive in Pick's disease) or to hypodopaminergia."1.29Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease. ( Lauterbach, EC, 1994)

Research

Studies (102)

TimeframeStudies, this research(%)All Research%
pre-199037 (36.27)18.7374
1990's19 (18.63)18.2507
2000's27 (26.47)29.6817
2010's16 (15.69)24.3611
2020's3 (2.94)2.80

Authors

AuthorsStudies
Kołaczkowski, M4
Marcinkowska, M4
Bucki, A4
Pawłowski, M4
Mitka, K1
Jaśkowska, J1
Kowalski, P1
Kazek, G2
Siwek, A4
Wasik, A2
Wesołowska, A4
Mierzejewski, P4
Bienkowski, P2
Śniecikowska, J3
Jastrzębska-Więsek, M3
Partyka, A3
Więckowski, K1
Głuch-Lutwin, M2
Gryboś, A1
Pytka, K2
Zagórska, A1
Jamrozik, M1
Jakubczyk, M1
Zhang, Y1
Wilkins, JM1
Bessette, LG1
York, C1
Wong, V1
Lin, KJ1
Chen, A1
Copeli, F1
Metzger, E1
Cloutier, A1
Osser, DN2
Nerius, M1
Johnell, K1
Garcia-Ptacek, S1
Eriksdotter, M1
Haenisch, B1
Doblhammer, G1
Stakišaitis, D1
Zamarytė-Sakavičienė, K1
Lesauskaitė, V1
Jankūnas, RJ1
O'Regan, NA1
Mohamad, MM1
Meagher, DJ1
Vilibić, M1
Jukić, V1
Vidović, A1
Brecić, P1
Gurwitz, D1
Morag, A1
Oved, K1
Langballe, EM1
Engdahl, B1
Nordeng, H1
Ballard, C1
Aarsland, D2
Selbæk, G1
Boettger, S1
Jenewein, J1
Breitbart, W1
Maust, DT1
Kim, HM2
Seyfried, LS2
Chiang, C2
Kavanagh, J1
Schneider, LS2
Kales, HC2
Ifteni, P1
Grudnikoff, E1
Koppel, J1
Kremen, N1
Correll, CU1
Kane, JM2
Manu, P1
Forlenza, OV1
Cretaz, E1
Diniz, BS1
Koch, HJ1
Nanev, D1
Becker, K1
Pisani, MA1
Murphy, TE1
Araujo, KL1
Van Ness, PH1
Rossom, RC1
Rector, TS1
Lederle, FA1
Dysken, MW1
Zivin, K1
Valenstein, M1
Cunningham, F1
Blow, FC1
Huybrechts, KF1
Gerhard, T1
Crystal, S1
Olfson, M1
Avorn, J1
Levin, R1
Lucas, JA1
Schneeweiss, S1
Bhan, S1
Kulkarni, V1
Mehta, Y1
Sharma, KK1
Trehan, N1
Suri, ML1
Battaglia, J1
Lindborg, SR2
Alaka, K2
Meehan, K1
Wright, P1
Beasley, CM1
Taylor, CC1
GERLE, B1
BUIS, C1
FLOHIL, JM1
SUGERMAN, AA1
WILLIAMS, BH1
ADLERSTEIN, AM1
Warner, J1
Butler, R1
Arya, P1
Greco, KE1
Tune, LE1
Brown, FW1
Van Horn, WA1
Suaudeau, C1
do-Rego, JC1
Costentin, J1
Finkel, S1
Kozma, C1
Long, S1
Greenspan, A1
Mahmoud, R1
Baser, O1
Engelhart, L1
Peitl, A1
Vucić Peitl, M1
Pavlović, E1
Ljubicić, D1
Suh, GH2
Greenspan, AJ2
Choi, SK2
Zuidema, SU1
van Iersel, MB1
Koopmans, RT1
Verhey, FR1
Olde Rikkert, MG1
Nassisi, D1
Korc, B1
Hahn, S1
Bruns, J1
Jagoda, A1
Jackson, GA1
Suzuki, T1
Uchida, H1
Watanabe, K1
Kashima, H1
Hollis, J1
Grayson, D1
Forrester, L1
Brodaty, H1
Touyz, S1
Cumming, R1
Preskorn, SH1
Ruths, S1
Straand, J1
Nygaard, HA1
Füessl, HS1
Selbaek, G1
Engedal, K1
Allen, RM1
Barbosa, ER1
Marchiori, PE1
Scaff, M1
de Assis, JL1
Götestam, KG1
Ljunghall, S1
Olsson, B1
Petrie, WM1
Ban, TA2
Berney, S1
Fujimori, M1
Guy, W1
Ragheb, M1
Wilson, WH1
Schaffer, JD1
Viukari, M1
Salo, H1
Lamminsivu, U1
Gordin, A1
Busch, KT1
Schulz, H1
Risberg, J1
Woerner, MG1
Alvir, JM1
Saltz, BL1
Lieberman, JA1
McSwain, ML1
Forman, LM1
Kimura, T1
Yoshida, H1
Lauterbach, EC1
Brock, G1
Gurekas, VL1
Thomas, JE1
Carlyle, W1
Ancill, RJ1
Sheldon, L1
Mowadat, HR1
Kerr, EE1
StClair, D1
Pitkälä, K1
Chang, WH1
Jann, MW1
Chiang, TS1
Lin, HN1
Hu, WH1
Chien, CP1
Sunderland, T1
Maany, I1
Auer, SR1
Monteiro, IM1
Reisberg, B1
Sultzer, DL1
Gray, KF1
Gunay, I1
Berisford, MA1
Mahler, ME1
Manos, PJ1
Wu, R1
Frenchman, IB1
Prince, T1
MacLennan, WJ1
De Deyn, PP2
Rabheru, K1
Rasmussen, A1
Bocksberger, JP1
Dautzenberg, PL1
Eriksson, S1
Lawlor, BA1
Windhaber, J1
Urbanits, S1
Grisold, W1
Katz, IR1
Maruka, Y1
Esumi, E1
Kojima, S1
Lonergan, E2
Luxenberg, J2
Colford, J2
Fine, F1
Walker, DJ1
ter Haar, HW1
Cowley, LM1
Glen, RS1
Pecknold, JC1
Silverman, G1
Thornton, WE1
Yudofsky, SC1
Silver, JM1
Hales, RE1
Coccaro, EF1
Kramer, E1
Zemishlany, Z1
Thorne, A1
Rice, CM1
Giordani, B1
Duvvi, K1
Patel, BM1
Torres, J1
Nora, R1
Kellner, CH1
Melvin, JA1
Hermesh, H1
Sirota, P1
Eviatar, J1
Janati, A1
Herrmann, N1
Lieff, SJ1
Stewart, TD1
Lovett, WC1
Stokes, DK1
Taylor, LB1
Young, ML1
Free, SM1
Phelan, DG1
Ciccone, PE1
Fayer, SA1
Ekbom, K1
Lindholm, H1
Ljungberg, L1
Walsh, AC1
Walsh, BH1
Rosin, AJ1
Crammer, JL1
Rosser, RM1
Crane, G1
Vangtorp, A1
Simmelsgaard, H1
Mellegaard, M1
Tobin, JM1
Brousseau, ER1
Lorenz, AA1
Tewfik, GI1
Jain, VK1
Harcup, M1
Magowan, S1
Tsuang, MM1
Lu, LM1
Stotsky, BA1
Cole, JO1
Helmchen, H1
Vallecorsi, G1
Bavazzano, A1
Radzuweit, H1
Knorr, W1
Buffa, B1
Cotta Ramusino, M1
Muti, M1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Feru-guard (Ferulic Acid and Angelica Archangelica Extract) for Behavioral Symptoms in Dementia[NCT03451760]Phase 270 participants (Anticipated)Interventional2018-09-30Not yet recruiting
Risperidone in the Treatment of Behavioral Disturbances in Demented Patients: an International, Multicenter, Placebo-controlled, Double-blind, Parallel-group Trial Using Haloperidol as Internal Reference[NCT00249145]Phase 3349 participants (Actual)Interventional1995-04-30Completed
Elderly Patients With Dementia in the Department of Acute Geriatrics: Pilot Study, Monocentric, Randomized Use of Aromatherapy as a Complementary Treatment to Psychopharmacotherapy in Psychological Disorders and BPSD Behavior[NCT03662360]32 participants (Actual)Interventional2018-05-20Completed
TRANSCRANIAL DIRECT CURRENT STIMULATION (t-DCS) AS ADD-ON TO NEUROREHABILITATION OF PISA SYNDROME IN PARKINSON DISEASE: A RANDOMIZED CONTROLLED TRIAL[NCT04620863]30 participants (Actual)Interventional2019-01-15Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Role of Essential Oil Therapy in Environmental Diffusion as a Complement of Psychotropic Drugs in the Management of Psychological and Behavioral Disorders (BPSD)

"The Neuropsychiatric Inventory - Nursing Home Version (NPI-NH) test will characterize the neuropsychiatric and psychopathological symptoms of patients affected by dementia.~Events as delirium, anxiety, depression, etc. will be recorded by the frequency (from 0, absence, to 4, high frequency) and the seriousness (from 0, absence, to 3, high). The total score of the NPI-NH is given by the frequency x (multiply) seriousness (total score for each event has a range from 0 to 12). The patient final score will be given by the sum of the score of the 12 events. For each patient will be given a total score from 0 to 144.~NPI NH score has been collected in both control and aromatherapy groups at T1 and T3, in patients who needed and who did not needed Pro Re Nata." (NCT03662360)
Timeframe: Time 1 (baseline) and Time 3 (day 7)

,
Interventionscore on a scale (Mean)
T1 NPI score in patients do not need Pro Re NataT3 NPI score in patients needed Pro Re NataT3 NPI score in patients do not need Pro Re Nata
GROUP A - Control Group21.8132.8720.00
GROUP B - Aromatherapy Group25.9316.57.25

Role of Essential Oil Therapy in Environmental Diffusion in Professional Caregiver Distress Linked to BPSD

NPI-NH assess the psychological distress in physicians, nurses and nursing assistants who managed the patients. It has a score from 0 (no discomfort) to score of 5 (extreme discomfort). The psychological distress is measured for each of the 12 events in the NPI-NH scale, for a total score from 0 to 60. (NCT03662360)
Timeframe: Time 1 (baseline) and Time 3 (day 7)

,
Interventionscore on a scale (Mean)
T1 NPI NH physicians in pts with PRNT1 NPI NH physicians in pts without PRNT1 NPI NH nurses in pts with PRNT1 NPI NH nurses in pts without PRNT1 NPI NH nursing assistants in pts with PRNT1 NPI NH nursing assistants in pts without PRNT3 NPI NH physician in pts with PRNT3 NPI NH physician in pts without PRNT3 NPI NH nurses in pts with PRNT3 NPI NH nurses in pts without PRNT3 NPI NH nursing assistants in pts with PRNT3 NPI NH nursing assistants in pts without PRN
GROUP A - Control Group4.191.609.636.4011.007.106.003.2012.009.3013.199.90
GROUP B - Aromatherapy Group5.644.1311.6410.1312.2110.882.640.885.794.255.934.38

Reviews

15 reviews available for haloperidol and Dementia

ArticleYear
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia.
    Psychiatry research, 2021, Volume: 295

    Topics: Academic Medical Centers; Aged; Algorithms; Antidepressive Agents; Antipsychotic Agents; Aripiprazol

2021
Off-Label Use of Antipsychotic Agents in Dementia: Evidence for the Revision of the Reimbursement Policy.
    Therapeutic innovation & regulatory science, 2019, Volume: 53, Issue:4

    Topics: Antipsychotic Agents; Dementia; European Union; Haloperidol; Humans; Insurance, Health, Reimbursemen

2019
[The use of antipsychotics in patients with dementia].
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2008, Volume: 30, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebrovascular Disorders; Dementia; Dementia,

2008
Dementia.
    Clinical evidence, 2004, Issue:11

    Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamin

2004
[Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
    Nederlands tijdschrift voor geneeskunde, 2006, Jul-15, Volume: 150, Issue:28

    Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Dementia; Haloperidol; Humans; Olanzapine; Psycho

2006
The evaluation and management of the acutely agitated elderly patient.
    The Mount Sinai journal of medicine, New York, 2006, Volume: 73, Issue:7

    Topics: Aged; Antipsychotic Agents; Benzodiazepines; Dementia; Diagnosis, Differential; Drug Therapy, Combin

2006
[Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases].
    No to shinkei = Brain and nerve, 1994, Volume: 46, Issue:9

    Topics: Aged; Aged, 80 and over; Dementia; Dementia, Vascular; Female; Haloperidol; Humans; Male; Middle Age

1994
[Confusional states in the elderly--an underdiagnosed syndrome with a poor prognosis].
    Nordisk medicin, 1996, Volume: 111, Issue:6

    Topics: Aged; Comorbidity; Confusion; Delirium; Dementia; Diagnosis, Differential; Haloperidol; Humans; Neur

1996
Treatment of the elderly suffering from psychosis and dementia.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 9

    Topics: Age Factors; Aged; Alzheimer Disease; Antipsychotic Agents; Buspirone; Clinical Trials as Topic; Dem

1996
Confusion: the cause is the key.
    The Practitioner, 1999, Volume: 243, Issue:1596

    Topics: Aged; Confusion; Dementia; Haloperidol; Humans; Hypnotics and Sedatives; Thioridazine

1999
Control of aggression and agitation in patients with dementia: efficacy and safety of risperidone.
    International journal of geriatric psychiatry, 2000, Volume: 15 Suppl 1

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Canada; Dementia; Dose-Response Relationship, Drug; D

2000
Haloperidol for agitation in dementia.
    The Cochrane database of systematic reviews, 2001, Issue:4

    Topics: Aggression; Anti-Dyskinesia Agents; Dementia; Haloperidol; Humans; Psychomotor Agitation; Randomized

2001
Haloperidol for agitation in dementia.
    The Cochrane database of systematic reviews, 2002, Issue:2

    Topics: Aggression; Anti-Dyskinesia Agents; Dementia; Haloperidol; Humans; Psychomotor Agitation; Randomized

2002
Haloperidol in the therapy of severe behavior disorders.
    Current psychiatric therapies, 1976, Volume: 16

    Topics: Benperidol; Bipolar Disorder; Child Behavior; Dementia; Droperidol; Haloperidol; Humans; Neurocognit

1976
Pharmacologic management of aggression in the elderly.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl

    Topics: Aged; Aggression; Antipsychotic Agents; Benzodiazepines; Buspirone; Dementia; Haloperidol; Humans; L

1990

Trials

21 trials available for haloperidol and Dementia

ArticleYear
Calming versus sedative effects of intramuscular olanzapine in agitated patients.
    The American journal of emergency medicine, 2003, Volume: 21, Issue:3

    Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dementia; Doubl

2003
Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients.
    Psychiatry research, 2003, Jul-15, Volume: 119, Issue:1-2

    Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dementia; Dose-Response Relationship, Drug;

2003
Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    International journal of geriatric psychiatry, 2006, Volume: 21, Issue:7

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Anxiety Disorders; Cross-Over Studies; Dementia; Doub

2006
Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS).
    International journal of geriatric psychiatry, 2008, Volume: 23, Issue:9

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Double-Blind Method; Femal

2008
A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia.
    Acta psychiatrica Scandinavica. Supplementum, 1981, Volume: 294

    Topics: Aged; Clinical Trials as Topic; Clopenthixol; Dementia; Double-Blind Method; Female; Haloperidol; Hu

1981
Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.
    Journal of clinical psychopharmacology, 1982, Volume: 2, Issue:2

    Topics: Aged; Clinical Trials as Topic; Dementia; Dibenzoxazepines; Double-Blind Method; Female; Haloperidol

1982
Tolerance and serum levels of haloperidol during parenteral and oral haloperidol treatment in geriatric patients.
    Acta psychiatrica Scandinavica, 1982, Volume: 65, Issue:4

    Topics: Administration, Oral; Aged; Delayed-Action Preparations; Dementia; Drug Tolerance; Female; Haloperid

1982
Neuroleptic treatment of elderly patients.
    Psychopharmacology bulletin, 1995, Volume: 31, Issue:2

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Brief Psychiatric Rating Scale; Dementia; Depressive

1995
Aggression in the demented patient: a double-blind study of loxapine versus haloperidol.
    International clinical psychopharmacology, 1993,Summer, Volume: 8, Issue:2

    Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Basal Ganglia Diseases; Dementia; Dementia,

1993
Behavioral symptoms in dementia: community-based research.
    International psychogeriatrics, 1996, Volume: 8 Suppl 3

    Topics: Aged; Alzheimer Disease; Ambulatory Care; Antipsychotic Agents; Dementia; Double-Blind Method; Femal

1996
A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 1997,Winter, Volume: 5, Issue:1

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dementia; D

1997
Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances.
    International psychogeriatrics, 1997, Volume: 9, Issue:4

    Topics: Aged; Antipsychotic Agents; Chi-Square Distribution; Dementia; Haloperidol; Humans; Retrospective St

1997
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.
    Neurology, 1999, Sep-22, Volume: 53, Issue:5

    Topics: Aged; Aged, 80 and over; Behavior; Dementia; Double-Blind Method; Female; Haloperidol; Humans; Male;

1999
The relief of restlessness in the elderly.
    Age and ageing, 1977, Volume: Suppl

    Topics: Activities of Daily Living; Aged; Chlormethiazole; Clinical Trials as Topic; Cognition; Confusion; D

1977
Double-blind study of thioridazine and haloperidol in geriatric patients with a psychosis associated with organic brain syndrome.
    The Journal of clinical psychiatry, 1979, Volume: 40, Issue:10

    Topics: Aged; Blood Pressure; Dementia; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged;

1979
Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients.
    The American journal of psychiatry, 1990, Volume: 147, Issue:12

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Diphenhydramine; D

1990
Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol.
    The Journal of clinical psychiatry, 1987, Volume: 48, Issue:6

    Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Dementia; Double-Blind Method; Female; Haloperido

1987
Experience with a new butyrophenone derivative (Buronil).
    Acta psychiatrica Scandinavica. Supplementum, 1968, Volume: 203

    Topics: Aged; Butyrophenones; Clinical Trials as Topic; Dementia; Female; Haloperidol; Humans; Male; Promazi

1968
Clinical evaluation of haloperidol in geriatric patients.
    Geriatrics, 1970, Volume: 25, Issue:6

    Topics: Aged; Clinical Trials as Topic; Dementia; Haloperidol; Humans; Psychomotor Disorders; Psychopharmaco

1970
Effectiveness of various tranquilisers in the management of senile restlessness.
    Gerontologia clinica, 1970, Volume: 12, Issue:6

    Topics: Aged; Carbamates; Chlorpromazine; Clinical Trials as Topic; Dementia; Female; Haloperidol; Humans; H

1970
Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study.
    Journal of the American Geriatrics Society, 1971, Volume: 19, Issue:7

    Topics: Activities of Daily Living; Aged; Clinical Trials as Topic; Dementia; Electrocardiography; Female; H

1971

Other Studies

66 other studies available for haloperidol and Dementia

ArticleYear
Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
    Journal of medicinal chemistry, 2014, Jun-12, Volume: 57, Issue:11

    Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Avoidance Learning; Benzoxazoles; Catalepsy; C

2014
Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
    European journal of medicinal chemistry, 2015, Mar-06, Volume: 92

    Topics: Animals; Benzamides; Dementia; Dose-Response Relationship, Drug; Drug Partial Agonism; Humans; Indol

2015
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity.
    Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17

    Topics: Affect; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Dementia; Dopamine Agonist

2017
Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD).
    European journal of medicinal chemistry, 2020, Apr-01, Volume: 191

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzoxazoles; Dementia; Dizocilpine Maleate; Dose-R

2020
Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization.
    JAMA network open, 2023, 02-01, Volume: 6, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cohort Studies; Delirium; Dementia; Female; Ha

2023
The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission, and Death in Dementia Patients.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2018, 09-11, Volume: 73, Issue:10

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Butyrophenones; Cohort Studies; Dementia; Female; Ger

2018
Impact of an educational workshop upon psychiatrists' attitudes towards delirium care.
    Irish journal of psychological medicine, 2019, Volume: 36, Issue:2

    Topics: Aged; Attitude of Health Personnel; Delirium; Dementia; Diagnosis, Differential; Haloperidol; Humans

2019
Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.
    Collegium antropologicum, 2013, Volume: 37, Issue:1

    Topics: Carbamazepine; Dementia; Diazepam; Electroencephalography; Haloperidol; Hematology; Humans; Hydroxoc

2013
A biological basis for the sex bias of antipsychotic drugs adverse events.
    Journal of the American Geriatrics Society, 2013, Volume: 61, Issue:8

    Topics: Aged; Antipsychotic Agents; Cell Line; Cell Proliferation; Dementia; Dose-Response Relationship, Dru

2013
Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2014, Volume: 22, Issue:4

    Topics: Aged; Aged, 80 and over; Ambulatory Care; Antipsychotic Agents; Cohort Studies; Dementia; Female; Ha

2014
Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
    Palliative & supportive care, 2015, Volume: 13, Issue:4

    Topics: Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Delirium; Dementia; Female; Haloperidol;

2015
Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
    JAMA psychiatry, 2015, Volume: 72, Issue:5

    Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Dementia;

2015
Haloperidol and sudden cardiac death in dementia: autopsy findings in psychiatric inpatients.
    International journal of geriatric psychiatry, 2015, Volume: 30, Issue:12

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Autopsy; Death, Sudden, Cardiac; Dementia; Female; Ha

2015
[Acute behaviour disorder in a patient with X-linked hydrocephalus with normal pressure].
    Wiener medizinische Wochenschrift (1946), 2009, Volume: 159, Issue:1-2

    Topics: Antipsychotic Agents; Bisoprolol; Dementia; Drug Therapy, Combination; Gait Disorders, Neurologic; G

2009
Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
    Prescrire international, 2009, Volume: 18, Issue:104

    Topics: Aged; Aggression; Alzheimer Disease; Antipsychotic Agents; Dementia; Drug Approval; Europe; France;

2009
Factors associated with persistent delirium after intensive care unit admission in an older medical patient population.
    Journal of critical care, 2010, Volume: 25, Issue:3

    Topics: Age Factors; Aged; Analgesics, Opioid; Analysis of Variance; Critical Care; Delirium; Dementia; Halo

2010
Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?
    Journal of the American Geriatrics Society, 2010, Volume: 58, Issue:6

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Comorbidity; Dementi

2010
Risk of mortality among individual antipsychotics in patients with dementia.
    The American journal of psychiatry, 2012, Volume: 169, Issue:1

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Dibenzothiazepines; Female

2012
Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study.
    BMJ (Clinical research ed.), 2012, Feb-23, Volume: 344

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cause of Death; Comorbidity; Dementia; Dibenzothiazep

2012
Neuroleptic malignant syndrome: uncommon postoperative diagnostic dilemma.
    Asian cardiovascular & thoracic annals, 2002, Volume: 10, Issue:4

    Topics: Aged; Bromocriptine; Coronary Artery Bypass; Coronary Artery Disease; Dementia; Diagnosis, Different

2002
[CLINICAL ASPECTS OF HALOPERIDOL].
    Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry, 1964, Volume: 18

    Topics: Dementia; Geriatrics; Haloperidol; Injections, Intramuscular; Mental Disorders; Neurotic Disorders;

1964
[CLINICAL EXPERIENCES WITH HALOPERIDOL (SERENASE)].
    Nederlands tijdschrift voor geneeskunde, 1964, Apr-18, Volume: 108

    Topics: Bipolar Disorder; Chlorpromazine; Chorea; Dementia; Depressive Disorder, Major; Epilepsy; Haloperido

1964
HALOPERIDOL IN THE PSYCHIATRIC DISORDERS OF OLD AGE.
    The American journal of psychiatry, 1964, Volume: 120

    Topics: Biomedical Research; Dementia; Geriatrics; Haloperidol; Intracranial Arteriosclerosis; Mental Disord

1964
A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:7

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Arrhythmias, Cardiac; Dementia; Electrocardiography;

2005
Modifications in avoidance reactions of mice, on a second exposure to the hot plate, resist to various amnesia-inducing treatments.
    Brain research. Cognitive brain research, 2005, Volume: 25, Issue:1

    Topics: Analysis of Variance; Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Dementia; Diaz

2005
Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    International psychogeriatrics, 2005, Volume: 17, Issue:4

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cerebrovascular Disorders; Cohort St

2005
Acute brain syndrome as a consequence of the Cronkhite-Canada syndrome.
    Psychiatria Danubina, 2005, Volume: 17, Issue:1-2

    Topics: Acute Disease; Aged; Dementia; Drug Therapy, Combination; Female; Haloperidol; Humans; Intestinal Po

2005
Assertion that risperidone is superior to haloperidol for treatment of behavioural and psychological symptoms of dementia.
    International journal of geriatric psychiatry, 2007, Volume: 22, Issue:3

    Topics: Antipsychotic Agents; Dementia; Haloperidol; Humans; Risperidone; Therapeutic Equivalency

2007
Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    International journal of geriatric psychiatry, 2007, Volume: 22, Issue:5

    Topics: Aged; Antipsychotic Agents; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Haloper

2007
Minimizing antipsychotic medication obviated the need for enema against severe constipation leading to paralytic ileus: a case report.
    Journal of clinical pharmacy and therapeutics, 2007, Volume: 32, Issue:5

    Topics: Aged; Antipsychotic Agents; Constipation; Dementia; Dose-Response Relationship, Drug; Drug Therapy,

2007
Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2007, Volume: 15, Issue:11

    Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepi

2007
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
    Journal of psychiatric practice, 2008, Volume: 14, Issue:1

    Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin;

2008
[Delirium in the old age].
    MMW Fortschritte der Medizin, 2008, Jan-24, Volume: 150, Issue:3-4

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antipsychotic Agents; Delirium; Dementia; Diagnosis,

2008
[Atypical antipsychotics in elderly patients with dementia].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, May-01, Volume: 128, Issue:9

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Haloperidol; Humans; Metho

2008
Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
    Biological psychiatry, 1982, Volume: 17, Issue:6

    Topics: Adult; Aged; Amantadine; Antipsychotic Agents; Dementia; Dose-Response Relationship, Drug; Drug Ther

1982
[Huntington chorea: report of 16 cases].
    Arquivos de neuro-psiquiatria, 1983, Volume: 41, Issue:2

    Topics: Adult; Aged; Brain Diseases; Chlorpromazine; Dementia; Diagnosis, Differential; Female; gamma-Aminob

1983
Clinical conferences: Management of depression in older people.
    Journal of the American Geriatrics Society, 1982, Volume: 30, Issue:3

    Topics: Aged; Antidepressive Agents; Dementia; Depressive Disorder; Desipramine; Diagnosis, Differential; Do

1982
[The acute psychiatric emergency].
    Zeitschrift fur Alternsforschung, 1981, Volume: 36, Issue:4

    Topics: Acute Disease; Aged; Alcoholism; Amitriptyline; Brain Ischemia; Cognition Disorders; Consciousness D

1981
Regional cerebral blood flow measurements by 133Xe-inhalation: methodology and applications in neuropsychology and psychiatry.
    Brain and language, 1980, Volume: 9, Issue:1

    Topics: Adult; Affective Symptoms; Aged; Alcoholism; Cerebrovascular Circulation; Computers; Dementia; Femal

1980
Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:4

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Drug Therapy, Combination; Haloperidol; Hum

1995
Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:3

    Topics: Affective Disorders, Psychotic; Brain; Dementia; Dose-Response Relationship, Drug; Electroencephalog

1994
The jumpy janitor. Letter to an ethicist.
    Canadian family physician Medecin de famille canadien, 1993, Volume: 39

    Topics: Aged; Aggression; Dementia; Ethics, Medical; Haloperidol; Humans; Inpatients; Long-Term Care; Male;

1993
Sporadic Pick's disease in a 28-year-old woman.
    The British journal of psychiatry : the journal of mental science, 1993, Volume: 162

    Topics: Adult; Atrophy; Carbamazepine; Dementia; Electroconvulsive Therapy; Female; Frontal Lobe; Haloperido

1993
Plasma haloperidol and reduced haloperidol concentrations in a geriatric population.
    Neuropsychobiology, 1996, Volume: 33, Issue:1

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Dementia; Dose-

1996
Adverse interaction of tacrine and haloperidol.
    The American journal of psychiatry, 1996, Volume: 153, Issue:11

    Topics: Aged; Dementia; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Parkinson

1996
The duration of delirium in medical and postoperative patients referred for psychiatric consultation.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1997, Volume: 9, Issue:4

    Topics: Aged; Delirium; Dementia; Female; Haloperidol; Humans; Length of Stay; Male; Middle Aged; Patient Ca

1997
Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
    Neurology, 2000, Apr-11, Volume: 54, Issue:7

    Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Dementia; Dose-Response Relationship, Drug; Halo

2000
Tandospirone, a promising alternative drug in the treatment of chorea.
    Internal medicine (Tokyo, Japan), 2000, Volume: 39, Issue:12

    Topics: Animals; Atrophy; Cerebral Cortex; Chorea; Dementia; Dopamine Antagonists; Female; Fluvoxamine; Halo

2000
Management of the elderly agitated demented patient.
    British medical journal, 1977, Aug-27, Volume: 2, Issue:6086

    Topics: Aged; Anti-Anxiety Agents; Dementia; Drug Combinations; Haloperidol; Humans; Lorazepam; Trihexypheni

1977
Management of the elderly agitated demented patient.
    British medical journal, 1977, Jul-30, Volume: 2, Issue:6082

    Topics: Aged; Dementia; Haloperidol; Humans

1977
Dementia induced by methyldopa with haloperidol.
    The New England journal of medicine, 1976, May-27, Volume: 294, Issue:22

    Topics: Adult; Anxiety; Dementia; Drug Synergism; Haloperidol; Humans; Hypertension; Male; Methyldopa; Middl

1976
Neuroleptic malignant syndrome associated with basal ganglia hemorrhage.
    The Journal of neuropsychiatry and clinical neurosciences, 1989,Summer, Volume: 1, Issue:3

    Topics: Aged; Basal Ganglia; Basal Ganglia Diseases; Cerebral Hemorrhage; Dementia; Haloperidol; Humans; Mal

1989
Recurrent neuroleptic malignant syndrome due to haloperidol and amantadine.
    Biological psychiatry, 1989, Apr-01, Volume: 25, Issue:7

    Topics: Aged; Amantadine; Dementia; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Malign

1989
Kluver-Bucy syndrome in Huntington's chorea.
    The Journal of nervous and mental disease, 1985, Volume: 173, Issue:10

    Topics: Adult; Agnosia; Behavior; Dementia; Dopamine; Feeding Behavior; Haloperidol; Humans; Huntington Dise

1985
Drug-induced catatonia.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1988, Volume: 33, Issue:7

    Topics: Aged; Aged, 80 and over; Catatonia; Dementia; Depressive Disorder; Drug Therapy, Combination; Female

1988
Agitation associated with dementia: neuroleptic malignant syndrome and fatal outcome in an 84-year-old man.
    Journal of clinical psychopharmacology, 1988, Volume: 8, Issue:6

    Topics: Aged; Aged, 80 and over; Dementia; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Neur

1988
Effectiveness of neuroleptics on behavioral symptoms in disturbed elderly patients.
    The Journal of clinical psychiatry, 1987, Volume: 48, Issue:12

    Topics: Aged; Dementia; Haloperidol; Humans; Neurocognitive Disorders; Trifluoperazine

1987
Torsades de pointes ventricular tachyarrhythmia associated with haloperidol.
    Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:6

    Topics: Aged; Dementia; Female; Haloperidol; Humans; Tachycardia

1986
New dystonic syndrome associated with butyrophenone therapy.
    Zeitschrift fur Neurologie, 1972, Volume: 202, Issue:2

    Topics: Amines; Antiparkinson Agents; Basal Ganglia; Butyrophenones; Dementia; Female; Gait; Haloperidol; Hu

1972
Presenile dementia: further experience with an anticoagulant-psychotherapy regimen.
    Journal of the American Geriatrics Society, 1974, Volume: 22, Issue:10

    Topics: Adult; Aged; Anticoagulants; Anxiety; Atrophy; Brain Diseases; Dementia; Dicumarol; Fear; Female; Ha

1974
Clinical features, etiology and treatment of facial dyskinesias in the elderly.
    Journal of the American Geriatrics Society, 1974, Volume: 22, Issue:11

    Topics: Age Factors; Aged; Brain; Brain Damage, Chronic; Brain Stem; Chorea; Dementia; Dopamine; Face; Femal

1974
Blood levels and management of lithium treatment.
    British medical journal, 1974, Sep-14, Volume: 3, Issue:5932

    Topics: Administration, Oral; Adult; Aged; Carbimazole; Delayed-Action Preparations; Dementia; Depression; D

1974
[Psychopharmacological agents in treatment of psychiatric emergencies].
    La Clinica terapeutica, 1971, Mar-31, Volume: 56, Issue:6

    Topics: Adult; Age Factors; Aged; Antidepressive Agents; Dementia; Diazepam; Haloperidol; Humans; Hypnotics

1971
[Haloperidol in the treatment of mental confusion in the aged].
    Giornale di gerontologia, 1971, Volume: 19, Issue:6

    Topics: Aged; Cognition Disorders; Dementia; Female; Haloperidol; Humans; Male; Psychomotor Disorders

1971
[Influencing of biological and immunologic pregnancy reactions by psychotropic drugs].
    Endokrinologie, 1969, Volume: 54, Issue:1

    Topics: Adolescent; Adult; Aged; Butyrophenones; Chlorpromazine; Dementia; Depressive Disorder, Major; Dysau

1969
[Haloperidol in states of psychomotor excitation and in anxiety states secondary to acute cardiocirculatory insufficiency].
    Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali, 1966, Dec-31, Volume: 90, Issue:6

    Topics: Aged; Anxiety Disorders; Coronary Disease; Dementia; Female; Haloperidol; Heart Diseases; Humans; Hy

1966
chemdatabank.com